pre-seed
Stage
1
Investors
About
KaloCyte develops ErythroMer™, a dried, bio-inspired artificial red blood cell designed to provide oxygen-carrying capacity in situations where stored red blood cells are unavailable, undesirable, or in short supply.
Explore KaloCyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.